DIA 2018 Global Annual Meeting has ended

Create Your Own Event

DIA 2018 Global Annual Meeting

8:30am EDT

#20: Real World Evidence Studies to Evaluate the Safety and Effectiveness of Therapeutic Interventions – Is the Data Fit for Purpose and How Will You Know? Room 157C #21: The IDMP Challenge: Points to Consider for Pharmacovigilance Departments Room 158 #22: Protocol Co-Design with Patients and Advocates Room 159 #23: R&D QA Comprehensive Quality Strategy: An Approach to Managing Quality Risks Throughout the Drug Development Lifecycle Room 160A #24: Preparing for a US FDA Advisory Committee Meeting Room 160B #25: Precedent: A Driver of Regulatory Strategy Room 160C #27: The Evolving Role of Payers in Drug Development: Pricing, Pharmacoeconomics, and Health Technology Assessment Room 161 #28: Preparing Documents for Disclosure and Public Sharing Room 162A #29: Leadership: How to Organize and Lead People in a Work Group Room 162B

9:00am EDT

#40: Smart, Innovative Risk-Based Auditing: Shifting the Paradigm Room 253C #42: Back to the Future: Combination Products in the 21st Century Room 256

1:00pm EDT

#30: Implementing a Risk-Based Monitoring Solution: Understanding the Basics of a Sustainable Model Room 160A #31: Machine Learning in Pharmacovigilance Room 160B #33: Quality Tolerance Limits/Issue Management: Taming the Beast of Clinical Development Risk Room 161 #34: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Effecting Pharmaceutical Development Room 159 #35: FDA Advisory Committee Purpose and Noninferiority Case Study: Rivaroxaban Room 162A #36: Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies Room 162B #37: Data Visualization in the Life Sciences Room 160C